Rongyang Li
Impact in
-
- Lung Cancer Diagnosis and Treatment
- Prostate Cancer Diagnosis and Treatment
- Ferroptosis and cancer prognosis
-
- Cancer Immunotherapy and Biomarkers
- Inflammatory Biomarkers in Disease Prognosis
Papers in
-
- Lung Cancer Diagnosis and Treatment 11
- Prostate Cancer Diagnosis and Treatment 2
- Lung Cancer Treatments and Mutations 2
- Ferroptosis and cancer prognosis 1
- Oncology 7
- Cancer Immunotherapy and Biomarkers 2
- Co-authors
- Hui Tian (15 shared papers)Weiming Yue (12 shared papers)Kun Wang (8 shared papers)Zhenguo Sun (2 shared papers)Bing Huang (1 shared paper)Hui Tian (1 shared paper)Hui Tian (9 shared papers)Zheng Ma (7 shared papers)
- Journals
- Frontiers in Oncology (8 papers)Translational Lung Cancer Research (4 papers)World Journal of Surgical Oncology (3 papers)Frontiers in Medicine (2 papers)Journal of Clinical Medicine (2 papers)
- Partner nations
- ChinaGermanyUnited States
In The Last Decade
Rongyang Li
34 papers receiving 244 citations
Peers
Comparison fields: 5 of 45
- Pulmonary and Respiratory Medicine 80
- Oncology 48
- Cancer Research 19
- Surgery 47
- Urology 5
Countries citing papers authored by Rongyang Li
This map shows the geographic impact of Rongyang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rongyang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rongyang Li more than expected).
Fields of papers citing papers by Rongyang Li
This network shows the impact of papers produced by Rongyang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rongyang Li. The network helps show where Rongyang Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Rongyang Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 34 | |
| 2 | 2023 | 28 | |
| 3 | 2023 | 18 | |
| 4 | 2022 | 13 | |
| 5 | 2021 | 13 | |
| 6 | 2022 | 11 | |
| 7 | 2023 | 10 | |
| 8 | 2023 | 10 | |
| 9 | 2022 | 9 | |
| 10 | 2022 | 9 | |
| 11 | 2023 | 8 | |
| 12 | 2022 | 8 | |
| 13 | 2021 | 8 | |
| 14 | Prognostic Significance and Therapeutic Target of CXC Chemokines in the Microenvironment of Lung Adenocarcinoma | 2022 | 7 |
| 15 | 2022 | 7 | |
| 16 | 2022 | 6 | |
| 17 | 2022 | 6 | |
| 18 | 2022 | 5 | |
| 19 | 2023 | 5 | |
| 20 | 2022 | 3 |
About Rongyang Li
Rongyang Li is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Molecular Biology and Sociology and Political Science, having authored 39 papers that have together received 246 indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (11 papers), Impact of Technology on Adolescents (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Prostate Cancer Diagnosis and Treatment (2 papers), Enhanced Recovery After Surgery (2 papers), Lung Cancer Treatments and Mutations (2 papers), Ferroptosis and cancer prognosis (1 paper) and Ubiquitin and proteasome pathways (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (80 citations), Oncology (48 citations), Cancer Research (19 citations), Surgery (47 citations) and Urology (5 citations). Rongyang Li has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Hui Tian, Weiming Yue, Kun Wang, Zhenguo Sun, Bing Huang, Hui Tian, Hui Tian, Zheng Ma, Wenhao Yu and Benkang Shi. Their work appears in journals such as Frontiers in Oncology, Translational Lung Cancer Research, World Journal of Surgical Oncology, Frontiers in Medicine and Journal of Clinical Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.